Global mergers and acquisitions activity passed its annual record on Monday, as Pfizer Inc.’s agreement to combine with Allergan Plc pushed the value of deals this year past highs set in 2007.
With a little more than five weeks left in 2015, the Pfizer-Allergan deal brings the value of M&A announced this year to $3.42 trillion, compared with the $3.4 trillion announced in the whole of 2007, according to data compiled by Bloomberg. The boom in activity is led by the mega deals that have been elusive since the global financial crisis stifled deal making; eight of the transactions agreed this year are worth more than $50 billion, compared to just two last year and one in 2013.
Read the full story at Bloomberg, by Manuel Baigorri
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
